Rein Therapeutics, Inc. (RNTX) › EPS (Basic)Rein Therapeutics, Inc. (RNTX) — EPS (Basic)Annual figures by period end, from SEC filings.2021-12-31: $-5.892022-12-31: $-6.022023-12-31: $-3.422024-12-31: $-3.512025-12-31: $-1.96$-1.962021-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-1.96—2026-03-26From 2025-01-012024-12-31$-3.51—2026-03-26From 2024-01-012023-12-31$-3.42—2025-04-07From 2023-01-012022-12-31$-6.02—2024-04-15From 2022-01-012021-12-31$-5.89—2023-03-20From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares